This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Hyperphosphatemia or Chronic Kidney Disease
and you are
over 18
years old
The phase for this study is not defined.
Show me locations

The purpose

The specific purpose of this study is to describe the characteristics of the K2CG chewing gum, specifically as it relates to duration of gum chewing (exposure), timing of gum chewing in relation to a meal, and dose of K2CG chewing gum.

Provided treatments

  • Other: K2CG chewing gum
  • Other: K2CG chewing gum
  • Other: K2CG chewing gum
  • Other: K2CG chewing gum

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01319578. The sponsor of the trial is Denver Nephrologists, P.C. and it is looking for 36 volunteers for the current phase.
Official trial title:
A Single Blind Pharmacodynamic Study to Assess the Phosphate Binding Characteristics of K2CG Chewing Gum